Literature DB >> 7998836

Expression and characterisation of the influenza A virus non-structural protein NS1 in yeast.

A C Ward1, A A Azad, I G Macreadie.   

Abstract

The influenza A virus non-structural protein NS1 was produced using a copper-inducible expression system in the yeast Saccharomyces cerevisiae. The protein produced had a molecular weight of 26 kDa by SDS-PAGE and was reactive with anti-NS1 antisera. The recombinant NS1 protein was targetted to the nucleolus/nuclear envelope fraction of the yeast cell nucleus, showing that its localisation signals remain functional in yeast. In addition, immune-electron microscopy detected cytoplasmic inclusions reminiscent of those seen in cells infected with some influenza strains. The NS1 protein was shown to be capable of in vivo self-interaction which probably forms the basis of its propensity to form inclusions. Expression of the protein was found to be toxic to yeast cells expressing it, supporting a role for the protein in the shutdown of influenza virus-infected cells. Deletion mapping of NS1 pointed to 2 regions of the molecule being important for this toxicity: a basic C-terminal stretch which has been shown to act as a nuclear localisation signal, and an N-terminal region implicated in RNA binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998836     DOI: 10.1007/BF01379133

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  40 in total

1.  Improved method for high efficiency transformation of intact yeast cells.

Authors:  D Gietz; A St Jean; R A Woods; R H Schiestl
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

2.  Analysis of influenza A virus temperature-sensitive mutants with mutations in RNA segment 8.

Authors:  E Hatada; M Hasegawa; K Shimizu; M Hatanaka; R Fukuda
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

3.  Influenza virus proteins. II. Association with components of the cytoplasm.

Authors:  R W Compans
Journal:  Virology       Date:  1973-01       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses.

Authors:  G L Smith; J Z Levin; P Palese; B Moss
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

6.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

7.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

8.  Isolation and characterization of cytoplasmic inclusions from influenza A virus-infected cells.

Authors:  M W Shaw; R W Compans
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

9.  Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. III. Genetic analysis of temperature-dependent host range mutants.

Authors:  K Shimizu; M G Mullinix; R M Chanock; B R Murphy
Journal:  Virology       Date:  1983-01-15       Impact factor: 3.616

10.  Vectors for Cu(2+)-inducible production of glutathione S-transferase-fusion proteins for single-step purification from yeast.

Authors:  A C Ward; L A Castelli; I G Macreadie; A A Azad
Journal:  Yeast       Date:  1994-04       Impact factor: 3.239

View more
  8 in total

1.  Novel influenza virus NS1 antagonists block replication and restore innate immune function.

Authors:  Dipanwita Basu; Marcin P Walkiewicz; Matthew Frieman; Ralph S Baric; David T Auble; Daniel A Engel
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

2.  Identification, design and synthesis of novel pyrazolopyridine influenza virus nonstructural protein 1 antagonists.

Authors:  Samarjit Patnaik; Dipanwita Basu; Noel Southall; Seameen Dehdashti; Kanny K Wan; Wei Zheng; Marc Ferrer; Mercedes Taylor; Daniel A Engel; Juan Jose Marugan
Journal:  Bioorg Med Chem Lett       Date:  2019-02-26       Impact factor: 2.823

Review 3.  The influenza virus NS1 protein as a therapeutic target.

Authors:  Daniel A Engel
Journal:  Antiviral Res       Date:  2013-06-21       Impact factor: 5.970

4.  Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds.

Authors:  Alex B Kleinpeter; Alexander S Jureka; Sally M Falahat; Todd J Green; Chad M Petit
Journal:  J Biol Chem       Date:  2018-08-03       Impact factor: 5.157

5.  Expression and analysis of the NS2 protein of influenza A virus.

Authors:  A C Ward; L A Castelli; A C Lucantoni; J F White; A A Azad; I G Macreadie
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 6.  New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.

Authors:  Grant Beyleveld; Kris M White; Juan Ayllon; Megan L Shaw
Journal:  Antiviral Res       Date:  2013-08-06       Impact factor: 5.970

Review 7.  Alternative Experimental Models for Studying Influenza Proteins, Host-Virus Interactions and Anti-Influenza Drugs.

Authors:  Sonja C J H Chua; Hui Qing Tan; David Engelberg; Lina H K Lim
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-30

8.  The Effector Domain of the Influenza A Virus Nonstructural Protein NS1 Triggers Host Shutoff by Mediating Inhibition and Global Deregulation of Host Transcription When Associated with Specific Structures in the Nucleus.

Authors:  Wolfgang Nacken; André Schreiber; Dörthe Masemann; Stephan Ludwig
Journal:  mBio       Date:  2021-09-07       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.